Aphthous ukers associated with imiquimod and the treatment of actinic cheilitis

被引：37
作者：
Chakrabarty, AK
Mraz, S
Geisse, MK
Anderson, NJ
机构：
[1] Solano Clin Res, Vallejo, CA 94589 USA
[2] Solano Clin Res, Davis, CA USA
[3] Univ Calif San Francisco, Dept Dermatol, San Francisco, CA 94143 USA
[4] Loma Linda Univ, Loma Linda, CA 92350 USA
来源：
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY | 2005年 / 52卷 / 02期
关键词：
D O I：
10.1016/j.jaad.2004.06.045
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
Our case series report is the first documented depiction of the appearance of aphthous ulcers secondary to imiquimod application. This case series presentation discusses the underlying pathophysiology of aphthous ulcer development and imiquimod therapy in terms of the stimulation of proinflammatory cytokines, such as tumor necrosis factor alpha (TNF-alpha), The literature review Suggests more than just a mere coincidence for the development of aphthous ulcers subsequent to the treatment of actinic cheilitis with imiquimod application.
引用
收藏
页码：S35 / S37
页数：3
相关论文
共 20 条
  • [1] Imiquimod: a novel treatment for lentigo maligna
    Ahmed, I
    Berth-Jones, J
    [J]. BRITISH JOURNAL OF DERMATOLOGY, 2000, 143 (04) : 843 - 845
  • [2] Ben Ahmed M, 2003, ADV EXP MED BIOL, V528, P343
  • [3] Therapeutic response of basal cell carcinoma to the immune response modifier imiquimod 5% cream
    Beutner, KR
    Geisse, JK
    Helman, D
    Fox, TL
    Ginkel, A
    Owens, ML
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1999, 41 (06) : 1002 - 1007
  • [4] Treatment of genital warts with an immune-response modifier (imiquimod)
    Beutner, KR
    Spruance, SL
    Hougham, AJ
    Fox, TL
    Owens, ML
    Douglas, JM
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1998, 38 (02) : 230 - 239
  • [5] BEUTNER KR, 1997, TODAYS THERAPEUTIC T, V15, P165
  • [6] The immunological and genetic basis of inflammatory bowel disease
    Bouma, G
    Strober, W
    [J]. NATURE REVIEWS IMMUNOLOGY, 2003, 3 (07) : 521 - 533
  • [7] Acute oral ulcers
    Bruce, AJ
    Rogers, RS
    [J]. DERMATOLOGIC CLINICS, 2003, 21 (01) : 1 - +
  • [8] Imiquimod 5% cream for the treatment of superficial basal cell carcinoma: Results from two phase III, randomized, vehicle-controlled studies
    Geisse, J
    Caro, I
    Lindholm, J
    Golitz, L
    Stampone, P
    Owens, M
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2004, 50 (05) : 722 - 733
  • [9] THALIDOMIDE EXERTS ITS INHIBITORY-ACTION ON TUMOR-NECROSIS-FACTOR-ALPHA BY ENHANCING MESSENGER-RNA DEGRADATION
    MOREIRA, AL
    SAMPAIO, EP
    ZMUIDZINAS, A
    FRINDT, P
    SMITH, KA
    KAPLAN, G
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1993, 177 (06) : 1675 - 1680
  • [10] Immunolocalization of tumor necrosis factor-α expressing cells in recurrent aphthous ulcer lesions (RAU)
    Natah, SS
    Häyrinen-Immonen, R
    Hietanen, J
    Malmström, M
    Konttinen, YT
    [J]. JOURNAL OF ORAL PATHOLOGY & MEDICINE, 2000, 29 (01) : 19 - 25
12